Abstract
Abstract Bacillus Calmette-Guerin (BCG) is the attenuated strain of Mycobacterium bovis. Intravesicular live attenuated BCG is one of the well-known effective treatments for transitional cell carcinoma of the bladder. Severe disseminated mycobacterial infections in such patients are uncommon. Here, we present a case of M. bovis mycotic aneurysm of the left femoral artery, diagnosed 14 months after initiation of intravesical BCG immunotherapy for bladder cancer. Although rare, given the significant morbidity and mortality associated with mycotic aneurysms, physicians should be aware of this complication in appropriate clinical scenarios and should have high index of suspicion; appropriate treatment should be initiated promptly.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
